NEW YORK (GenomeWeb) – Natera reported after the close of the market Thursday that its second quarter revenues jumped 15 percent year over year as its test volume rose sharply.

The San Carlos, California-based molecular diagnostics firm reported total revenues of $52 million, up from $45.1 million for Q2 2015 and besting the consensus Wall Street estimate of $50.6 million.